Fernanda Morales Berstein1,2, Daniel L McCartney3, Ake T Lu4, Konstantinos K Tsilidis5,6, Emmanouil Bouras6, Philip Haycock1,2, Kimberley Burrows1,2, Amanda I Phipps7,8, Daniel D Buchanan9, Iona Cheng10, Richard M Martin1,2,11, George Davey Smith1,2, Caroline L Relton1,2, Steve Horvath4,12, Riccardo E Marioni3, Tom G Richardson1,2,13, Rebecca C Richmond1,2. 1. MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. 2. Population Health Sciences, Bristol Medical School, Bristol, United Kingdom. 3. Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. 4. Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States. 5. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. 6. Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece. 7. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States. 8. Department of Epidemiology, School of Public Health, University of Washington, Seattle, United States. 9. Department of Clinical Pathology, Melbourne Medical School, University of Melbourne, Parkville, Australia. 10. Cancer Prevention Institute of California, Fremont, United States. 11. National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom. 12. Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, United States. 13. Novo Nordisk Research Centre, Oxford, United Kingdom.
Abstract
Background: Epigenetic clocks have been associated with cancer risk in several observational studies. Nevertheless, it is unclear whether they play a causal role in cancer risk or if they act as a non-causal biomarker. Methods: We conducted a two-sample Mendelian randomization (MR) study to examine the genetically predicted effects of epigenetic age acceleration as measured by HannumAge (nine single-nucleotide polymorphisms (SNPs)), Horvath Intrinsic Age (24 SNPs), PhenoAge (11 SNPs), and GrimAge (4 SNPs) on multiple cancers (i.e. breast, prostate, colorectal, ovarian and lung cancer). We obtained genome-wide association data for biological ageing from a meta-analysis (N = 34,710), and for cancer from the UK Biobank (N cases = 2671-13,879; N controls = 173,493-372,016), FinnGen (N cases = 719-8401; N controls = 74,685-174,006) and several international cancer genetic consortia (N cases = 11,348-122,977; N controls = 15,861-105,974). Main analyses were performed using multiplicative random effects inverse variance weighted (IVW) MR. Individual study estimates were pooled using fixed effect meta-analysis. Sensitivity analyses included MR-Egger, weighted median, weighted mode and Causal Analysis using Summary Effect Estimates (CAUSE) methods, which are robust to some of the assumptions of the IVW approach. Results: Meta-analysed IVW MR findings suggested that higher GrimAge acceleration increased the risk of colorectal cancer (OR = 1.12 per year increase in GrimAge acceleration, 95% CI 1.04-1.20, p = 0.002). The direction of the genetically predicted effects was consistent across main and sensitivity MR analyses. Among subtypes, the genetically predicted effect of GrimAge acceleration was greater for colon cancer (IVW OR = 1.15, 95% CI 1.09-1.21, p = 0.006), than rectal cancer (IVW OR = 1.05, 95% CI 0.97-1.13, p = 0.24). Results were less consistent for associations between other epigenetic clocks and cancers. Conclusions: GrimAge acceleration may increase the risk of colorectal cancer. Findings for other clocks and cancers were inconsistent. Further work is required to investigate the potential mechanisms underlying the results. Funding: FMB was supported by a Wellcome Trust PhD studentship in Molecular, Genetic and Lifecourse Epidemiology (224982/Z/22/Z which is part of grant 218495/Z/19/Z). KKT was supported by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme) and by the Hellenic Republic's Operational Programme 'Competitiveness, Entrepreneurship & Innovation' (OΠΣ 5047228). PH was supported by Cancer Research UK (C18281/A29019). RMM was supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol and by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme). RMM is a National Institute for Health Research Senior Investigator (NIHR202411). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. GDS and CLR were supported by the Medical Research Council (MC_UU_00011/1 and MC_UU_00011/5, respectively) and by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme). REM was supported by an Alzheimer's Society project grant (AS-PG-19b-010) and NIH grant (U01 AG-18-018, PI: Steve Horvath). RCR is a de Pass Vice Chancellor's Research Fellow at the University of Bristol.
Background: Epigenetic clocks have been associated with cancer risk in several observational studies. Nevertheless, it is unclear whether they play a causal role in cancer risk or if they act as a non-causal biomarker. Methods: We conducted a two-sample Mendelian randomization (MR) study to examine the genetically predicted effects of epigenetic age acceleration as measured by HannumAge (nine single-nucleotide polymorphisms (SNPs)), Horvath Intrinsic Age (24 SNPs), PhenoAge (11 SNPs), and GrimAge (4 SNPs) on multiple cancers (i.e. breast, prostate, colorectal, ovarian and lung cancer). We obtained genome-wide association data for biological ageing from a meta-analysis (N = 34,710), and for cancer from the UK Biobank (N cases = 2671-13,879; N controls = 173,493-372,016), FinnGen (N cases = 719-8401; N controls = 74,685-174,006) and several international cancer genetic consortia (N cases = 11,348-122,977; N controls = 15,861-105,974). Main analyses were performed using multiplicative random effects inverse variance weighted (IVW) MR. Individual study estimates were pooled using fixed effect meta-analysis. Sensitivity analyses included MR-Egger, weighted median, weighted mode and Causal Analysis using Summary Effect Estimates (CAUSE) methods, which are robust to some of the assumptions of the IVW approach. Results: Meta-analysed IVW MR findings suggested that higher GrimAge acceleration increased the risk of colorectal cancer (OR = 1.12 per year increase in GrimAge acceleration, 95% CI 1.04-1.20, p = 0.002). The direction of the genetically predicted effects was consistent across main and sensitivity MR analyses. Among subtypes, the genetically predicted effect of GrimAge acceleration was greater for colon cancer (IVW OR = 1.15, 95% CI 1.09-1.21, p = 0.006), than rectal cancer (IVW OR = 1.05, 95% CI 0.97-1.13, p = 0.24). Results were less consistent for associations between other epigenetic clocks and cancers. Conclusions: GrimAge acceleration may increase the risk of colorectal cancer. Findings for other clocks and cancers were inconsistent. Further work is required to investigate the potential mechanisms underlying the results. Funding: FMB was supported by a Wellcome Trust PhD studentship in Molecular, Genetic and Lifecourse Epidemiology (224982/Z/22/Z which is part of grant 218495/Z/19/Z). KKT was supported by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme) and by the Hellenic Republic's Operational Programme 'Competitiveness, Entrepreneurship & Innovation' (OΠΣ 5047228). PH was supported by Cancer Research UK (C18281/A29019). RMM was supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol and by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme). RMM is a National Institute for Health Research Senior Investigator (NIHR202411). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. GDS and CLR were supported by the Medical Research Council (MC_UU_00011/1 and MC_UU_00011/5, respectively) and by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme). REM was supported by an Alzheimer's Society project grant (AS-PG-19b-010) and NIH grant (U01 AG-18-018, PI: Steve Horvath). RCR is a de Pass Vice Chancellor's Research Fellow at the University of Bristol.
Authors: Christopher DeBoever; Yosuke Tanigawa; Matthew Aguirre; Greg McInnes; Adam Lavertu; Manuel A Rivas Journal: Am J Hum Genet Date: 2020-04-09 Impact factor: 11.025
Authors: Maria N Timofeeva; Rayjean J Hung; Thorunn Rafnar; David C Christiani; John K Field; Heike Bickeböller; Angela Risch; James D McKay; Yufei Wang; Juncheng Dai; Valerie Gaborieau; John McLaughlin; Darren Brenner; Steven A Narod; Neil E Caporaso; Demetrius Albanes; Michael Thun; Timothy Eisen; H-Erich Wichmann; Albert Rosenberger; Younghun Han; Wei Chen; Dakai Zhu; Margaret Spitz; Xifeng Wu; Mala Pande; Yang Zhao; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Maiken Elvestad Gabrielsen; Frank Skorpen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Simone Benhamou; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Thomas Muley; Hendrik Dienemann; Gudmar Thorleifsson; Hongbing Shen; Kari Stefansson; Paul Brennan; Christopher I Amos; Richard Houlston; Maria Teresa Landi Journal: Hum Mol Genet Date: 2012-08-16 Impact factor: 6.150
Authors: Haoyu Zhang; Thomas U Ahearn; Julie Lecarpentier; Daniel Barnes; Jonathan Beesley; Guanghao Qi; Xia Jiang; Tracy A O'Mara; Ni Zhao; Manjeet K Bolla; Alison M Dunning; Joe Dennis; Qin Wang; Zumuruda Abu Ful; Kristiina Aittomäki; Irene L Andrulis; Hoda Anton-Culver; Volker Arndt; Kristan J Aronson; Banu K Arun; Paul L Auer; Jacopo Azzollini; Daniel Barrowdale; Heiko Becher; Matthias W Beckmann; Sabine Behrens; Javier Benitez; Marina Bermisheva; Katarzyna Bialkowska; Ana Blanco; Carl Blomqvist; Natalia V Bogdanova; Stig E Bojesen; Bernardo Bonanni; Davide Bondavalli; Ake Borg; Hiltrud Brauch; Hermann Brenner; Ignacio Briceno; Annegien Broeks; Sara Y Brucker; Thomas Brüning; Barbara Burwinkel; Saundra S Buys; Helen Byers; Trinidad Caldés; Maria A Caligo; Mariarosaria Calvello; Daniele Campa; Jose E Castelao; Jenny Chang-Claude; Stephen J Chanock; Melissa Christiaens; Hans Christiansen; Wendy K Chung; Kathleen B M Claes; Christine L Clarke; Sten Cornelissen; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Mary B Daly; Peter Devilee; Orland Diez; Susan M Domchek; Thilo Dörk; Miriam Dwek; Diana M Eccles; Arif B Ekici; D Gareth Evans; Peter A Fasching; Jonine Figueroa; Lenka Foretova; Florentia Fostira; Eitan Friedman; Debra Frost; Manuela Gago-Dominguez; Susan M Gapstur; Judy Garber; José A García-Sáenz; Mia M Gaudet; Simon A Gayther; Graham G Giles; Andrew K Godwin; Mark S Goldberg; David E Goldgar; Anna González-Neira; Mark H Greene; Jacek Gronwald; Pascal Guénel; Lothar Häberle; Eric Hahnen; Christopher A Haiman; Christopher R Hake; Per Hall; Ute Hamann; Elaine F Harkness; Bernadette A M Heemskerk-Gerritsen; Peter Hillemanns; Frans B L Hogervorst; Bernd Holleczek; Antoinette Hollestelle; Maartje J Hooning; Robert N Hoover; John L Hopper; Anthony Howell; Hanna Huebner; Peter J Hulick; Evgeny N Imyanitov; Claudine Isaacs; Louise Izatt; Agnes Jager; Milena Jakimovska; Anna Jakubowska; Paul James; Ramunas Janavicius; Wolfgang Janni; Esther M John; Michael E Jones; Audrey Jung; Rudolf Kaaks; Pooja Middha Kapoor; Beth Y Karlan; Renske Keeman; Sofia Khan; Elza Khusnutdinova; Cari M Kitahara; Yon-Dschun Ko; Irene Konstantopoulou; Linetta B Koppert; Stella Koutros; Vessela N Kristensen; Anne-Vibeke Laenkholm; Diether Lambrechts; Susanna C Larsson; Pierre Laurent-Puig; Conxi Lazaro; Emilija Lazarova; Flavio Lejbkowicz; Goska Leslie; Fabienne Lesueur; Annika Lindblom; Jolanta Lissowska; Wing-Yee Lo; Jennifer T Loud; Jan Lubinski; Alicja Lukomska; Robert J MacInnis; Arto Mannermaa; Mehdi Manoochehri; Siranoush Manoukian; Sara Margolin; Maria Elena Martinez; Laura Matricardi; Lesley McGuffog; Catriona McLean; Noura Mebirouk; Alfons Meindl; Usha Menon; Austin Miller; Elvira Mingazheva; Marco Montagna; Anna Marie Mulligan; Claire Mulot; Taru A Muranen; Katherine L Nathanson; Susan L Neuhausen; Heli Nevanlinna; Patrick Neven; William G Newman; Finn C Nielsen; Liene Nikitina-Zake; Jesse Nodora; Kenneth Offit; Edith Olah; Olufunmilayo I Olopade; Håkan Olsson; Nick Orr; Laura Papi; Janos Papp; Tjoung-Won Park-Simon; Michael T Parsons; Bernard Peissel; Ana Peixoto; Beth Peshkin; Paolo Peterlongo; Julian Peto; Kelly-Anne Phillips; Marion Piedmonte; Dijana Plaseska-Karanfilska; Karolina Prajzendanc; Ross Prentice; Darya Prokofyeva; Brigitte Rack; Paolo Radice; Susan J Ramus; Johanna Rantala; Muhammad U Rashid; Gad Rennert; Hedy S Rennert; Harvey A Risch; Atocha Romero; Matti A Rookus; Matthias Rübner; Thomas Rüdiger; Emmanouil Saloustros; Sarah Sampson; Dale P Sandler; Elinor J Sawyer; Maren T Scheuner; Rita K Schmutzler; Andreas Schneeweiss; Minouk J Schoemaker; Ben Schöttker; Peter Schürmann; Leigha Senter; Priyanka Sharma; Mark E Sherman; Xiao-Ou Shu; Christian F Singer; Snezhana Smichkoska; Penny Soucy; Melissa C Southey; John J Spinelli; Jennifer Stone; Dominique Stoppa-Lyonnet; Anthony J Swerdlow; Csilla I Szabo; Rulla M Tamimi; William J Tapper; Jack A Taylor; Manuel R Teixeira; MaryBeth Terry; Mads Thomassen; Darcy L Thull; Marc Tischkowitz; Amanda E Toland; Rob A E M Tollenaar; Ian Tomlinson; Diana Torres; Melissa A Troester; Thérèse Truong; Nadine Tung; Michael Untch; Celine M Vachon; Ans M W van den Ouweland; Lizet E van der Kolk; Elke M van Veen; Elizabeth J vanRensburg; Ana Vega; Barbara Wappenschmidt; Clarice R Weinberg; Jeffrey N Weitzel; Hans Wildiers; Robert Winqvist; Alicja Wolk; Xiaohong R Yang; Drakoulis Yannoukakos; Wei Zheng; Kristin K Zorn; Roger L Milne; Peter Kraft; Jacques Simard; Paul D P Pharoah; Kyriaki Michailidou; Antonis C Antoniou; Marjanka K Schmidt; Georgia Chenevix-Trench; Douglas F Easton; Nilanjan Chatterjee; Montserrat García-Closas Journal: Nat Genet Date: 2020-05-18 Impact factor: 38.330
Authors: Daniel L McCartney; Josine L Min; Rebecca C Richmond; Ake T Lu; Maria K Sobczyk; Gail Davies; Linda Broer; Xiuqing Guo; Ayoung Jeong; Jeesun Jung; Silva Kasela; Seyma Katrinli; Pei-Lun Kuo; Pamela R Matias-Garcia; Pashupati P Mishra; Marianne Nygaard; Teemu Palviainen; Amit Patki; Laura M Raffield; Scott M Ratliff; Tom G Richardson; Oliver Robinson; Mette Soerensen; Dianjianyi Sun; Pei-Chien Tsai; Matthijs D van der Zee; Rosie M Walker; Xiaochuan Wang; Yunzhang Wang; Rui Xia; Zongli Xu; Jie Yao; Wei Zhao; Steve Horvath; Riccardo E Marioni; Adolfo Correa; Eric Boerwinkle; Pierre-Antoine Dugué; Peter Durda; Hannah R Elliott; Christian Gieger; Eco J C de Geus; Sarah E Harris; Gibran Hemani; Medea Imboden; Mika Kähönen; Sharon L R Kardia; Jacob K Kresovich; Shengxu Li; Kathryn L Lunetta; Massimo Mangino; Dan Mason; Andrew M McIntosh; Jonas Mengel-From; Ann Zenobia Moore; Joanne M Murabito; Miina Ollikainen; James S Pankow; Nancy L Pedersen; Annette Peters; Silvia Polidoro; David J Porteous; Olli Raitakari; Stephen S Rich; Dale P Sandler; Elina Sillanpää; Alicia K Smith; Melissa C Southey; Konstantin Strauch; Hemant Tiwari; Toshiko Tanaka; Therese Tillin; Andre G Uitterlinden; David J Van Den Berg; Jenny van Dongen; James G Wilson; John Wright; Idil Yet; Donna Arnett; Stefania Bandinelli; Jordana T Bell; Alexandra M Binder; Dorret I Boomsma; Wei Chen; Kaare Christensen; Karen N Conneely; Paul Elliott; Luigi Ferrucci; Myriam Fornage; Sara Hägg; Caroline Hayward; Marguerite Irvin; Jaakko Kaprio; Deborah A Lawlor; Terho Lehtimäki; Falk W Lohoff; Lili Milani; Roger L Milne; Nicole Probst-Hensch; Alex P Reiner; Beate Ritz; Jerome I Rotter; Jennifer A Smith; Jack A Taylor; Joyce B J van Meurs; Paolo Vineis; Melanie Waldenberger; Ian J Deary; Caroline L Relton Journal: Genome Biol Date: 2021-06-29 Impact factor: 17.906